Back to home

Easyhaler® Budesonide (Budesonide)

Product info | 01/12/2020
Easyhaler<sup>®</sup> Budesonide (Budesonide)

beh-image@2x.png

 

FULL PRESCRIBING INFORMATION CAN BE FOUND HERE

 

indication@2x.png dosing-options@2x.png the-environment@2x.png bts-guidelines@2x.png

 

 

indications.png

PRESENTATIONS:
Budesonide 100mcg, 200mcg and 400mcg

INDICATION:
For treatment of mild, moderate or severe persistant asthma for patients aged 6 and above.

CONTRAINDICATIONS:
Easyhaler Budesonide is contraindicated in patients with hypersensitivity to budesonide, lactose or milk proteins.

UNDESIRABLE EFFECTS:
The common reported adverse events are cough and throat irritation, oropharyngeal candidiasis and difficulty in swallowing.
Prescribers should consult the SmPC in relation to special warnings and precautions.

top.png

 

 

dosing-options.png

WITH EASYHALER® BUDESONIDE YOU CAN1 :
✔ Prescribe a low dose ICS for new patients with Easyhaler Budesonide (budesonide).
✔ Use flexible daily dosing with children and adults (see below for dosing regimes).

once-daily-dosing.png

twice-daily-dosing.png

top.png

 

 

the-environment.png

EASYHALER® BUDESONIDE provides you with a low carbon option
for your inhaled corticosteroid prescribing so you can:

✔ Reduce your MDI prescribing
✔ Prescribe a range of drug therapies within the Easyhaler® range and have the flexibility to move patients across the BTS / SIGN guidelines to find and maintain the lowest controlling therapy2

 

ESTIMATED CARBON FOOTPRINT OF DPIs and MDIs (per 200 actuations)3

estimated-carbon-footprint-graph_new.png

* Numbers refer to class of hydrofluorocarbon (HFC) refrigerant

Figure 1: Estimated carbon footprint of DPIs and MDIs (per 200 actuations) adapted from: Montreal protocol on substances that deplete the ozone layer. Medical and chemicals technical options committee. Assessment report 2018

 

BTS / SIGN = British Thoracic Society / Scottish Intercollegiate Guidelines Network, ICS = Inhaled Corticosteroids, DPI = Dry Powder Inhaler, MDI = Metered Dose Inhalers.
SmPC = Summary of Product Characteristics

top.png

 

REFERENCES:

  1. Easyhaler Budesonide 100, 200, and 400 mcg. SmPC. Orion Pharma.
  2. BTS/SIGN. British guidelines on the Management of Asthma - a national clinical guideline. SIGN 158 Revised July 2019. https://www.britthoracic.org.uk/qualityimprovement/guidelines/asthma/
  3. Montreal protocol on substances that deplete the ozone layer. Medical and chemicals technical options committee. Assessment report 2018.

 


March 2021 / RESP-330bbg(1)

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd on
01635 520300.

ORIONPHARMA.CO.UK

 

Full prescribing information available here

 

MAY 2021 / RESP-330b(3)

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.

Orion Pharma (UK) Ltd, Abbey Gardens, 4 Abbey Street, Reading, RG1 3BA, UK | Tel: +44 1635 520 300 | February 2021 / RESP-330(1)
Policies Contact us Orion Corporation 2021